Charles River Laboratories International, Inc. (NYSE:CRL) Stock Quotes and News

Charles River Laboratories International, Inc. (CRL) 44.35 -0.97

Price Open:	45.04	Day's Range:	0.00000 - 46.88000
Price Close:	44.99	52wk Range:	0.00000 - 46.88000
Price Day Change:	-0.97	Volume:	536,523
Price % Change:	-2.16	Market Cap:	2.158B
Bid:	0.00000	PE Ratio:	22.53
Ask:	46.00000	EPS Diluted:	1.997

Trade CRL NOW!

The Latest On CRL

Earnings Scheduled For May 1, 2013 5/1/13 4:58am

Benzinga's Top Initiations 3/18/13 8:47am

UPDATE: Bank of America Initiates Charles River Laboratories at Neutral on Valuation 3/18/13 8:09am

UPDATE: ISI Group Reiterates Neutral Rating, Raises PT on Charles River Laboratories on In-Line 4Q12 2/20/13 3:15pm

UPDATE: Jefferies Upgraded Charles River Laboratories to Buy on Tailwinds 2/19/13 8:53am

Earnings Scheduled For February 13, 2013 2/13/13 3:13am

UPDATE: Sterne Agee Reiterates Buy Rating, Raises PT on Charles River Laboratories 1/14/13 3:10pm

Charles River Labs Closes Purchase of Majority Ownership of Vital River 1/7/13 6:00pm

UPDATE: JP Morgan Upgrades Charles River Laboratories to Overweight on Risk/Reward 12/13/12 1:06pm

Benzinga's Top Upgrades 12/13/12 8:07am

Mid-Afternoon Market Update: Bernanke Press Conference Leads to Drop in the Markets 12/12/12 4:56pm

Mid-Day Market Update: Fed to Continue Stimulus, Markets Rise 12/12/12 3:26pm

Press Releases

Charles River Laboratories to Present at Baird's Growth Stock Conference 5/6/13 Business Wire

Charles River Laboratories Announces First-Quarter 2013 Results from Continuing Operations 5/1/13 Business Wire

Charles River Laboratories Schedules First-Quarter 2013 Earnings Release and Conference Call 4/8/13 Business Wire

Charles River Laboratories to Present at March Investor Conferences 3/1/13 Business Wire

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2012 Results from Continuing Operations 2/13/13 Business Wire

Charles River Laboratories Schedules Fourth-Quarter and Full-Year 2012 Earnings Release and Conference Call 1/22/13 Business Wire

Charles River Laboratories Completes Acquisition of Majority Ownership of Vital River 1/7/13 Business Wire

Charles River Laboratories to Present at J.P. Morgan Healthcare Conference 1/7/13 Business Wire

Charles River Laboratories Provides 2013 Financial Guidance 12/12/12 Business Wire

Charles River Laboratories Schedules 2013 Guidance Release and Conference Call 11/29/12 Business Wire

Get the latest CRL stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Charles River Laboratories International, Inc. stock price.

Partner Headlines

ABCO Posts Solid 4Q and FY2013 Earnings - Analyst Blog 5/13/13

Charles River Misses Estimates in 1Q - Analyst Blog 5/2/13

The "Healthy" Play In Contract Research Organizations 4/17/13

Parexel Stock Hits New High As Buyback Ramps Up 3/15/13

Charles River Laboratories International Inc (CRL) Chairman, President and CEO James C Foster ... 3/1/13

Mixed 4Q for Charles River - Analyst Blog 2/14/13

Robert Olstein's Largest New Stock Picks 2/12/13

Weekly CFO Sells HIGHLIGHT: TMO, BLOX, VRSK, CRL, INGR, GWRE 1/13/13

Charles River Acquires Vital River - Analyst Blog 1/8/13

Charles River Laboratories International Inc (CRL) Corp. ... 1/8/13

BASi Introduces Culex NxT - Analyst Blog 1/3/13